SEARCH OF THE STRESS INDUSED VENTRICULAR TACHICARDIA REASONS — THE METABOLIC THERAPY OPPORTUNITIES

A clinical case of a 56-year-old man is presented in which only ventricular tachycardia without clinical and ECG criteria of myocardial ischemia is recorded on the exercise test. The ventricular tachycardia was the only reason for stopping the test. This clinical case demonstrates all the difficulties in determining the genesis of ventricular arrhythmias induced by exercise. The purpose of the work was to show all the difficulties in determining the genesis of exercise-induced ventricular arrhythmia. The literature references related to the exercise-induced ventricular arrhythmia differentiation is rather poor. It is only known that if a patient develops and progresses ventricular arrhythmia, a tredmill test is considered questionable. Exerciseinduced ventricular arrhythmias especially ventricular tachycardia, are the most dangerous. Therefore, additional diagnostic methods were used to reveal the main disease as the background of ventricular tachycardia. Results of pharmacological test with nitroglycerine were the indication of the ischemic origin of ventricular tachycardia. Coronary angiography did not reveal coronary artery stenoses. Positron emission tomography revealed coronary microcirculation disturbance after which a decision about metabolic therapy with Mexicor was made. The correct choice of the drug (Mеxisor) was confirmed by the results of control studies — improvement of metabolism and antiarrhythmic effect. The article concludes that the choice of the treatment exercise-induced ventricular arrhythmia in patients with stable coronary artery disease should be individual and pathogenetic.

stable coronary artery disease, ventricular arrhythmias, ventricular tachycardia, Holter monitoring, exercise test

1. Priori S.G., Blomström-Lundqvist C., Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. http://eurheartj.oxfordjournals.org.

2. Treshkur T.V. Clinical and electrocardiographic characteristics of ischemic ventricular arrhythmias. Vestnik Aritmologii. 2002; 30: 31–9 [In Russian].

3. Wittstein I.S., Thiemann D.R., Lima J.A.C. et al. Neurohumoral Features of Myocardial Strunning Due to Sudden Emotional Stress. N Eng J Med. 2005; 35: 539–48.

4. Lampert R., Jain D., Burg M.M. et al. Destabilizing Effects of Mental Stress on Ventricular Arrhythmias in Patients with Implantable Cardioverter-Defibrillators. Circulation. 2000; 101: 158-164.

5. Ryngach E.A., Treshkur T.V, Tatarinova A.A. et al. Algorithm for the management of patients with stable coronary artery disease and high-grade ventricular arrhythmias. Therapeutic Archive. 2017; 89(1): 94-102. [In Russian].

6. Montalescot G., Sechtem U., Achenbach S. et al. 2013 ESC Guidelines on the management of stable coronary artery disease. European Heart Journal. 2013; 34: 2949-3003.

7. Pedersen C.T., Kayemai l.G., Kalman N.J. et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014; 11(10): 166-96.

8. Treshkur T., Panova E., Chmelevsky M. et al. Determination of genesis and localization of ventricular ectopic focus in a patient with coronary artery disease. Exp Clin Cardiol. 2014; 20(8): 2388-2394.

9. Zhabina E.S., Tulintseva T.E., Ryngach E.A. et al. Ventricular arrhythmias induced by exercise. Vestnik Aritmologii. 2017; 87: 49-54 [In Russian].

10. Hanson M.W., Morris E.I., Borges-Neto S. et al. Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias. Journal of Nuclear Cardiology. 1997; 4(5): 372–378.

11. Makarov L.M., Komolyatova V.N., Kupriyanova O.O. et al. Russian National recommendations on the use of techniques Holter monitoring in clinical practice. Journal of Cardiology. 2014; 2(106): 6—71 [In Russian].

12. Аронов Д.М., Лупанов В.П. Функциональные пробы в кардиологии. Москва. МЕДпресс-информ. 2003: 68-69.

13. Aronov D.M., Lupanov V.P. Functional tests in cardiology. Moskva. MEDpress-inform. 2003: 68-69 [In Russian].

14. Karpov Yu.A., Kukharchuk V.V., Lyakishev A.A. et al. Diagnosis and treatment of chronic ischemic heart disease. Klinicheskie rekomendatsii. Moskva 2013 [In Russian].

15. Тreshkur T.V., Parmon E.V., Demidova M.M. et al. Method for diagnosing ischemic ventricular arrhythmias in patients with coronary artery disease 2006. Internet resource: http://bd.patent.su/22800002280999/pat/servl/servlet4390.html. (Date of the application: 05.07.18.) [In Russian].

16. Shlyakhto E.V., Treshkur T.V., Parmon E.V. et al Possibilities of metabolic therapy in patients with ischemic ventricular arrhythmias. Vestnik Aritmologii. 2006; 44: 5-11. [In Russian].

17. Tsapko L.P., Afanasiev S.A., Maksimov I.V. Prospects for metabolic therapy in the heart diseases. The Siberian medical journal. 2016; 31(4): 7-13 [In Russian].

18. Tsvetkova O.A., Gracheva E.I. The role of metabolic therapy in the treatment of coronary heart disease. Russian Medical Journal. 2013; 4: 225-231 [In Russian].

19. Ryngach E.A., Tatarinova A.A., Ryzhkova D.V. et al. Antiarrhythmic action of cardiocytoprotectors in treatment of ischemic heart disease with ventricular arrhythmias. Russ J Cardiol. 2016; 9(137): 29–34 [In Russian].

20. Syrensky A.V., Galagudza M.M., Egorova E.I. et al. Influence of changes in the metabolic and antioxidant status of the myocardium on the severity of its ischemic and reperfusion defect. Russian Journal of Physiology. 2008; 94 (10): 1171-1180 [In Russian].

21. Mikhin V.P., Kharchenko A.V., Nikolenko T.A. et al. A study of the efficacy of Mexicor for the treatment of rhythm disturbances in patients with coronary heart disease Kursk scientific and practical herald «Man and his health». 2008; 4: 74-81[In Russian].

22. Yagudina R.I., Ovchinnikova L.K., Arinina E.E. Practical recommendations on the choice of medicines. Collection of algorithms for choosing drugs. Remedium. 2010; 384 р. [In Russian].

23. Windecker St., Kolh Ph., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2014; 35(37): 2541-619.

24. Noda Т., Shimizu W., Taguchi A. et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiolоgy. 2005; 46(7): 12881294.

25. Santoro F., Biase L. Di, Hranitzky P. et al. Ventricular fibrillation triggered by PVCs from papillary muscles: clinical features and ablation. J Cardiovasc Electrophysiology. 2014; 25(11): 1158-1164.

26. Vakhlyaev V.D., Nedostup A.V., Tsaregorodtsev D.A. et al. The role of humoral factors in the pathogenesis of cardiac arrhythmias. Russian Medical Journal. 2000; 2: 54-57 [In Russian].

27. Ignarro L.J., Wei Lun. Nitric oxide in the regulation of vascular function: an historical overview. J Card Surg. 2002; 17(4): 301-6.

28. Klocke J., Baird M.G., Lorell B.H. et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging. Circulation. 2003; 108: 1404.

29. Hesse B., Lindhardt T.B., Acampa W. et al. EANM/ESC guidelines for radionuclide imaging. Eur. J. Nucl. Med Mol Imaging. 2008; 35(4): 851-885.

30. Ryzhkova D.V., Savicheva I.Yu., Tyutin L.A. The use of positron emission tomography with a new radiopharmaceutical 11С-butyrate sodium for evaluation of myocardial state in patients with ischemic heart disease. Herald of radiology and radiology. 1999; 5:18-21 [In Russian].